A Phase II Study of Gemcitabine in Combination with Tanespimycin in Advanced Epithelial Ovarian and Primary Peritoneal Carcinoma

OBJECTIVE: To evaluate the efficacy and biological effects of the gemcitabine/tanespimycin combination in patients with advanced ovarian and peritoneal cancer. To assess the effect of tanespimycin on tumor cells, levels of the chaperone proteins HSP90 and HSP70 were examined in peripheral blood mono...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Wahner Hendrickson, Andrea E., Oberg, Ann L., Glaser, Gretchen, Camoriano, John K., Peethambaram, Prema P., Colon-Otero, Gerardo, Erlichman, Charles, Ivy, Percy, Kaufmann, Scott H., Karnitz, Larry M., Haluska, Paul
Format: Artigo
Jezik:Inglês
Izdano: 2011
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3265019/
https://ncbi.nlm.nih.gov/pubmed/22047770
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2011.10.002
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items